Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

18 Dec 2006 07:01

Ark Therapeutics Group PLC18 December 2006 ARK THERAPEUTICS GROUP PLC Notification of Major Interests in Shares 18 December 2006 Ark Therapeutics Group plc (LSE: AKT) announces that on 15 December 2006 itreceived notification that, pursuant to the Companies Act 1985, FMR Corp. andits direct and indirect subsidiaries, and Fidelity International Ltd (FIL) andits direct and indirect subsidiaries (being non-beneficial holders), hold6,418,921 shares, representing 4.02% of the issued ordinary share capital of ArkTherapeutics Group plc prior to the placing of such shares. Such sharesrepresent 3.87% of the enlarged issued share capital of the Company. The registered holders of the shares are listed on the schedule below. Nick Plummer (Company Secretary) From: Fidelity International "Dear Sirs Enclosed are notifications of disclosable interests under the UK Companies Act1985. Please note that while this information details the disclosable interestsof more than one entity, the enclosed disclosure constitutes separatenotifications of interest which have been combined solely for purposes ofclarity and efficiency. It is not intended to indicate that any of theseentities act as a group or in concert with respect to these interests. These disclosures are made in the interest of conformity with the Companies Act.The interest detailed herein were acquired solely for investment purposes.For disclosure purposes, holdings should be represented as FMR Corp. and itsdirect and indirect subsidiaries, and Fidelity International Limited (FIL) andits direct and indirect subsidiaries, both being non-beneficial holders." NOTIFICATIONS UNDER SECTIONS 198 TO 202 - UK COMPANIES ACT 1. Company in which shares are held: Ark Therapeutics Group plc 2. Notifiable Interest: Ordinary Shares (A) FMR Corp. 82 Devonshire Street Boston, MA 02109 Parent holding company of Fidelity Management & Research Company (FMRCO), investment manager for US mutual funds, and Fidelity Management Trust Company (FMTC), a US state chartered bank which acts as a trustee or investment manager of various pension and trust accounts. (See Schedule A for listing of Registered Shareholders and their holdings). (B) Fidelity International Limited (FIL) P.O. Box HM 670 Hamilton HMCX, Bermuda Parent holding company for various direct and indirect subsidiaries, including Fidelity Investment Services Ltd. (FISL), Fidelity Gestion (FIGEST), Fidelity Investments Advisory (Korea) Limited (FIA(K)L), Fidelity Investments Management (Hong Kong) Limited (FIMHK), Fidelity Pension Management (FPM) and Fidelity Investments International (FII), investment managers for various non-US investment companies and institutional clients. 3. The notifiable interests also comprise the notifiable interest of: Mr. Edward C. Johnson 3d 82 Devonshire Street Boston, MA 02109 A principal shareholder of FMR Corp, and Fidelity International Limited. 4. The notifiable interests include interest held on behalf of authorized unit trust schemes in the UK, notwithstanding the exemption from reporting pursuant to Section 209 (1 )(h) of the Companies Act 1985. 5. These notifications of disclosable interests constitute separate notifications of interest in the shares and are combined solely for the purposes of clarity and efficiency. Nothing herein should be taken to indicate that FMR Corp. and its direct and indirect subsidiaries, Fidelity International Limited and its direct and indirect subsidiaries or Mr. Edward C. Johnson 3d act as a group or in concert in respect of the disclosed interests, or that they are required to submit these notifications on a joint basis. 6. The disclosable interests arise under section 208 (4) (b) of the Act, namely where a person, not being the registered holder, is entitled to exercise a right conferred by the holding of the shares or to control the exercise of such rights, or under section 203 of the Act respectively. Schedule A ARK THERAPEUTICS GROUP PLC Current ownership percentage 4.02% Total Shares Held 6,418,921 Shares in Issue: 159,522,573 Shares Held Management Company Nominee/Registered Name 207,600 FIJ BROWN BROTHERS HARRIMAN AND CO4,475,300 FIL BROWN BROS HARRIMN LTD LUX231,486 FIL STATE STR BK AND TR CO LNDN (S44,035 FISL JP MORGAN, BOURNEMOUTH179,300 FPM BANK OF NEW YORK BRUSSELS575,200 FPM CITIBANK LONDON706,000 FPM JP MORGAN, BOURNEMOUTH This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Sep 20205:21 pmRNSResult of General Meeting
23rd Sep 20203:15 pmRNSDirector/PDMR Shareholding
17th Sep 20203:21 pmRNSDirector/PDMR Shareholding
17th Sep 202010:59 amRNSHolding(s) in Company
17th Sep 202010:57 amRNSDirector/PDMR Shareholding
16th Sep 20203:14 pmRNSDirector/PDMR Shareholding
2nd Sep 20207:00 amRNSDelisting, Posting of Circular and Notice of AGM
17th Aug 20207:00 amRNSHolding(s) in Company
13th Aug 20207:00 amRNSAcquisition and Delisting
26th Jun 20207:00 amRNSInterim Results
22nd Jun 20207:00 amRNSBlock listing Interim Review
4th May 20207:00 amRNSBusiness Update and Financing
14th Apr 202012:07 pmRNSSecond Price Monitoring Extn
14th Apr 202012:02 pmRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSAGM Update
31st Jan 20204:52 pmRNSFinal Results
29th Jan 20207:00 amRNSConfirmation of Funding
23rd Dec 20191:01 pmRNSTrading Update
20th Dec 20197:00 amRNSBlock listing six monthly return
5th Jul 20197:00 amRNSNEW CONTRACT WITH MEDIVET GROUP
28th Jun 20197:00 amRNSInterim results for 6 months ended 31 March 2019
25th Jun 20197:00 amRNSAppointment of Broker and Interim results update
20th Jun 201912:05 pmRNSBLOCK LISTING SIX MONTHLY RETURN
23rd Apr 20193:37 pmRNSDirector/PDMR Shareholding
23rd Apr 20193:35 pmRNSDirector/PDMR Shareholding
23rd Apr 20193:35 pmRNSIssue of Warrants
23rd Apr 201910:58 amRNSDirector/PDMR Shareholding
8th Apr 20195:50 pmRNSHolding(s) in Company
27th Mar 20192:46 pmRNSResult of AGM
27th Mar 20197:00 amRNSAGM Update
27th Feb 201910:40 amRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSNotice of AGM
11th Feb 20192:59 pmRNSHolding(s) in Company
8th Feb 20197:00 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSPRELIMINARY ANNOUNCEMENT
29th Jan 20197:00 amRNSConfirmation of Funding
18th Jan 20197:00 amRNSNotice of Results
9th Jan 20194:07 pmRNSTrading Update
20th Dec 201810:48 amRNSBlock listing Interim Review
24th Oct 20187:00 amRNSTrading Update
13th Sep 20187:00 amRNSAppointment of Chief Financial Officer
6th Sep 201812:21 pmRNSHolding(s) in Company
29th Aug 20187:00 amRNSNeil Wood MBE joins Board of PVG plc
22nd Aug 20187:00 amRNSDirectorate Change
15th Aug 20187:00 amRNSMajor contract signed in the US
3rd Aug 20182:58 pmRNSHolding(s) in Company
25th Jun 20185:44 pmRNSNotification of Major Holdings
20th Jun 20184:33 pmRNSBlock listing Interim Review
15th Jun 20187:00 amRNSInterim Results
27th Mar 20184:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.